New Data on Phase 3 Trial of Quinsair for Cystic Fibrosis Presented by Raptor at European CF Conference
Cystic Fibrosis, News
At the 39th European Cystic Fibrosis Conference, recently held in Basel, Switzerland, Raptor Pharmaceutical presented new data on its Phase 3 MPEX-209 clinical trial comparing Quinsair to inhaled tobramycin solution in patients ... Read more